Stock SUNZEN SUNZEN BIOTECH
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sunzen Biotech

Equities

SUNZEN

MYQ0148OO005

Food Processing

End-of-day quote BURSA MALAYSIA
Other stock markets
 06:00:00 2024-06-04 pm EDT 		5-day change 1st Jan Change
0.38 MYR -1.30% Intraday chart for Sunzen Biotech -1.30% +26.67%
May. 24 Sunzen Biotech Berhad Reports Earnings Results for the Third Quarter Ended March 31, 2024 CI
May. 06 Sunzen Biotech Berhad executed a non-binding Term Sheet to acquire 70% stake in Eye Nation Medical Sdn.Bhd from Mr. Lee Peng Hwa and Madam Lay Lee Chin for MYR 6.37 million CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 149.3 86.46 55.52 95.18 176.5 140.9
Enterprise Value (EV) 1 103 50.95 38.89 71.44 134.5 133.9
P/E ratio 47.7 x -12 x -3.41 x -7.19 x 227 x 42.6 x
Yield 0.97% - - - - -
Capitalization / Revenue 0.49 x 0.29 x 0.23 x 1.16 x 1.95 x 1.45 x
EV / Revenue 0.34 x 0.17 x 0.16 x 0.87 x 1.49 x 1.38 x
EV / EBITDA 26.3 x -4.85 x -2.44 x -6.56 x 21.7 x 13.4 x
EV / FCF -121 x -5.3 x -2.5 x -33 x 9.79 x -310 x
FCF Yield -0.82% -18.9% -40% -3.03% 10.2% -0.32%
Price to Book 1.5 x 0.81 x 0.61 x 1.09 x 1.49 x 1.16 x
Nbr of stocks (in thousands) 481,620 524,023 528,765 528,765 705,817 704,603
Reference price 2 0.3100 0.1650 0.1050 0.1800 0.2500 0.2000
Announcement Date 4/27/18 4/30/19 6/29/20 5/28/21 4/28/22 4/26/23
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 303.5 300.4 240.6 82.23 90.48 97.09
EBITDA 1 3.908 -10.5 -15.92 -10.9 6.195 10.02
EBIT 1 2.919 -12.9 -19.15 -13.48 3.92 7.815
Operating Margin 0.96% -4.29% -7.96% -16.39% 4.33% 8.05%
Earnings before Tax (EBT) 1 4.012 -6.94 -19.63 -12.7 3.705 7.462
Net income 1 3.474 -6.939 -16.25 -13.23 0.6801 3.749
Net margin 1.14% -2.31% -6.75% -16.09% 0.75% 3.86%
EPS 2 0.006499 -0.0137 -0.0308 -0.0250 0.001100 0.004699
Free Cash Flow 1 -0.8488 -9.604 -15.54 -2.168 13.74 -0.4324
FCF margin -0.28% -3.2% -6.46% -2.64% 15.18% -0.45%
FCF Conversion (EBITDA) - - - - 221.77% -
FCF Conversion (Net income) - - - - 2,020.02% -
Dividend per Share 2 0.003000 - - - - -
Announcement Date 4/27/18 4/30/19 6/29/20 5/28/21 4/28/22 4/26/23
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 46.3 35.5 16.6 23.7 42 6.98
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.85 -9.6 -15.5 -2.17 13.7 -0.43
ROE (net income / shareholders' equity) 3.69% -6.47% -18.6% -13.5% 1.77% 3.74%
ROA (Net income/ Total Assets) 1.62% -6.05% -8.68% -6.69% 1.8% 3.26%
Assets 1 214.6 114.8 187.3 197.8 37.75 115
Book Value Per Share 2 0.2100 0.2000 0.1700 0.1700 0.1700 0.1700
Cash Flow per Share 2 0.1000 0.0800 0.0600 0.0700 0.0700 0.0200
Capex 1 3.42 1.94 4.02 1.16 2.4 2.19
Capex / Sales 1.13% 0.64% 1.67% 1.41% 2.65% 2.25%
Announcement Date 4/27/18 4/30/19 6/29/20 5/28/21 4/28/22 4/26/23
1MYR in Million2MYR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Food Processing

1st Jan change Capi.
SUNZEN BIOTECH Stock Sunzen Biotech
+26.67% 57.19M
NESTLÉ S.A. Stock Nestlé S.A.
+0.58% 286B
MONDELEZ INTERNATIONAL, INC. Stock Mondelez International, Inc.
-6.14% 91.19B
KRAFT HEINZ Stock Kraft Heinz
-6.25% 42.1B
DANONE Stock Danone
+1.16% 41.5B
THE HERSHEY COMPANY Stock The Hershey Company
+6.39% 40.11B
GENERAL MILLS, INC. Stock General Mills, Inc.
+3.56% 38.08B
ARCHER-DANIELS-MIDLAND COMPANY Stock Archer-Daniels-Midland Company
-15.44% 30.2B
NESTLÉ INDIA LIMITED Stock Nestlé India Limited
-6.98% 29.01B
ASSOCIATED BRITISH FOODS PLC Stock Associated British Foods plc
+8.79% 24.6B
Other Food Processing
  1. Stock Market
  2. Equities
  3. SUNZEN Stock
  4. Financials Sunzen Biotech